Upregulated expressions of E2A, FOXO1, or FOXP1 enhanced RAG1 expression, while silencing of E2A, FOXO1, or FOXP1 decreased RAG1 expression in the cancer cells. This evidence concerns the gene FOXP1 and cancer.